Langkampfen, Austria

Julia Leibold

Average Co-Inventor Count = 7.2

ph-index = 12

Forward Citations = 282(Granted Patents)

Forward Citations (Not Self Cited) = 112(Sep 21, 2024)

Location History:

  • Langkampfen, DE (2020)
  • Tuebingen, DE (2018 - 2022)
  • Langkampfen, AT (2019 - 2023)


Years Active: 2018-2023

where 'Filed Patents' based on already Granted Patents

26 patents (USPTO):
1 patent (CIPO):

Title: The Innovative Contributions of Julia Leibold in Cancer Immunotherapy

Introduction: Julia Leibold, based in Langkampfen, Austria, is a prominent inventor known for her significant contributions in the field of immunotherapy. With an impressive portfolio, she holds 26 patents, underscoring her dedication to advancing medical science, particularly in cancer treatment.

Latest Patents: Julia's latest innovation focuses on peptides and combinations of peptides aimed at immunotherapy against prostate cancer and other malignancies. Her invention discusses the use of peptides, proteins, nucleic acids, and cells in immunotherapeutic methods. Specifically, it delves into tumor-associated T-cell peptide epitopes that can serve as active pharmaceutical ingredients in vaccine compositions. These vaccines are designed to stimulate anti-tumor immune responses or to enhance T-cell activation ex vivo for patient transfer. Additionally, peptides bound to molecules of the major histocompatibility complex (MHC), as well as the peptides themselves, can act as targets for antibodies and other binding molecules, further illustrating the versatility of her work.

Career Highlights: Julia Leibold's career is marked by her tenure at Immatics Biotechnologies GmbH, where she continues to push the boundaries of cancer research. Her commitment to innovation is evident in her extensive patent portfolio and ongoing research endeavors.

Collaborations: Throughout her career, Julia has collaborated with esteemed colleagues, including Toni Weinschenk and Andrea Mahr. These partnerships have played a crucial role in enhancing her research and patent developments, fostering a collaborative environment focused on groundbreaking medical advancements.

Conclusion: Julia Leibold's work in immunotherapy demonstrates her remarkable innovative spirit and dedication to combating cancer. With her numerous patents and collaborative efforts, she continues to inspire advancements in medical research that have the potential to transform cancer treatments and improve patient outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…